DB Futils

Main Menu

  • Home
  • Acquisition Of Stock
  • Forward Integration
  • Free Entry
  • Zero Balance Account
  • Borrowing

DB Futils

Header Banner

DB Futils

  • Home
  • Acquisition Of Stock
  • Forward Integration
  • Free Entry
  • Zero Balance Account
  • Borrowing
Acquisition Of Stock
Home›Acquisition Of Stock›Cochlear share price drops following ‘loss-making’ acquisition of Oticon Medical

Cochlear share price drops following ‘loss-making’ acquisition of Oticon Medical

By Deanna Day
April 28, 2022
0
0

Image source: Getty Images

the Cochlear Limited (ASX:COH) the stock price is trading lower on Thursday morning.

As of this writing, shares of the hearing solutions company are down 1% at $228.92.

Why is the Cochlear stock price falling?

Investors sold Cochlear’s share price on Thursday after an acquisition announcement was released after the market closed yesterday.

According to the statement, Cochlear has agreed to pay A$170 million to acquire cochlear implants and bone conduction hearing solution provider Oticon Medical from Danish hearing care company Demant. This follows Demant’s decision to exit its business activities related to hearing implants.

As part of the transaction, Cochlear has agreed to provide ongoing support to Oticon Medical’s base of over 75,000 hearing implant recipients, which includes cochlear and acoustic implants.

However, the deal still has a few closing conditions to meet before it closes. These include customary closing conditions and the receipt of competition approvals in jurisdictions where the transaction meets the relevant notification thresholds.

If all goes as planned, the acquisition will be funded from its existing cash balances and is expected to close in the second half of 2022.

What was the reaction?

According to a note from Goldman Sachs, its analysts seem to believe the deal could be good. And while it won’t make much of a difference to its market share, the broker points out that it offers greater scale and supports industry pricing.

Goldman commented:[G]Greater scale would allow COH to reinvest more in product development (as it always has), which would further strengthen the company’s position in the market. The acquisition of Oticon would also likely support industry pricing, as Oticon was previously seen as one of the market challengers with prices below the industry average.

Management commentary

The market doesn’t seem as convinced based on Cochlear’s share price performance. Especially since the acquired company is currently operating at a loss.

Nonetheless, Cochlear CEO and Chairman Dig Howitt is very positive about the deal. He said:

“The acquisition of Oticon Medical will give us greater scale and enable us to increase our investments in R&D and market growth activities. While Cochlear is a market leader in implantable hearing, we are a small player in the hearing loss segment where hearing aids remain the primary treatment option.

Our goal is to improve the penetration of implantable hearing solutions, build customer awareness and confidence, and provide more patients with the hearing solutions best suited to their individual needs.

Mr. Howitt also referred to Oticon Medical’s lack of profit. He added:

“Oticon Medical is expected to add AUD 75-80 million to its annual turnover. The company is currently loss-making. Our priority after closing the transaction will be to determine and implement a plan that will return the business to profitability as quickly as possible. Integration costs, which include the development of compatible next-generation sound processors, are yet to be determined and could range from $30 million to $60 million. We continue to target a long-term net profit margin of 18%. »

Related posts:

  1. The acquisition of Moka locations Mogo within the Main League FinTech
  2. RP Acquisition Company acquires the property of Inventory + Discipline | Instances-Republic of Iroquois County
  3. Northern Genesis Acquisition Corp. and Lion Electrical Announce Efficient Date of Registration Assertion and Particular Assembly of April 23, 2021 to Approve Enterprise Mixture
  4. Purchase SNPR Inventory’s Pullback Earlier than Merger with Volta

Recent Posts

  • Free Hessie Trailhead shuttle begins Friday, May 27
  • NJ firefighters get millions for protective gear
  • Paytm’s acquisition of general insurer Raheja Qbe canceled as it misses deadline
  • Belvoir is hosting a ‘Best of British’ weekend to celebrate the Queen’s Platinum Jubilee
  • Adit EdTech Acquisition Corp. (NYSE:ADEX) sees a significant increase in short-term interest

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • January 2020
  • December 2019
  • October 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • October 2017
  • August 2017
  • March 2017

Categories

  • Acquisition Of Stock
  • Borrowing
  • Forward Integration
  • Free Entry
  • Zero Balance Account
  • Terms and Conditions
  • Privacy Policy